CVS Health Corp (CVS)

In the past 90 days, CVS Health Corp has recorded seven insider trading transactions, with a net value of approximately -$253.6 million, primarily driven by significant selling activity from insider Larry Robbins. Notably, Robbins executed multiple large sell transactions totaling over $113 million on May 2, 2025. In contrast, a single buy transaction by Guy P. Sansone on June 5, 2025, amounted to $100,009. The company's stock has seen a modest price increase of 2.3% over the same period, following an earnings report that exceeded expectations by 34.55%.

Track

Stock chart
Ticker: CVS Exchange: NYS


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Earnings
 
Value bought

Past 90 days

 
Value sold

Past 90 days

 
Net insiders buying

Past 90 days

 
Trades (buy and sell)

Past 90 days

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-06-09 2025-06-05 B Purchase

SANSONE GUY P

Non-Executive Director
1,000 +15.0%
63.70
USD 100,009 		1,000 +15.0% 63.70 USD 100,000
2025-05-06 2025-05-06 S Sale

ROBBINS LARRY

Non-Executive Director
150,000 -1.8%
66.67
USD 10,000,710 		150,000 -1.8% 66.67 USD 10,000,710
2025-05-06 2025-05-05 S Sale

ROBBINS LARRY

Non-Executive Director
96,999 -1.1%
67.99
USD 6,595,272 		96,999 -1.1% 67.99 USD 6,595,272
2025-05-06 2025-05-05 S Sale

ROBBINS LARRY

Non-Executive Director
1,226,933 -12.7%
67.37
USD 82,654,673 		1,226,933 -12.7% 67.37 USD 82,654,673
2025-05-06 2025-05-02 S Sale

ROBBINS LARRY

Non-Executive Director
373,776 -3.7%
69.66
USD 26,035,592 		373,776 -3.7% 69.66 USD 26,035,592
2025-05-06 2025-05-02 S Sale

ROBBINS LARRY

Non-Executive Director
222,556 -2.2%
68.38
USD 15,218,980 		222,556 -2.2% 68.38 USD 15,218,980
2025-05-06 2025-05-02 S Sale

ROBBINS LARRY

Non-Executive Director
1,679,736 -14.1%
67.39
USD 113,190,186 		1,679,736 -14.1% 67.39 USD 113,190,186
2025-03-07 2025-03-05 S Sale

Clark James David

SVP, Cont & Chief Acct Officer

Officer
7,513 -47.2%
66.35
USD 498,488 		7,513 -47.2% 66.35 USD 498,488
2025-02-19 2025-02-18 B Purchase

Mahoney Michael F

Non-Executive Director
30,000 +320.6%
66.70
USD 2,001,000 		30,000 +320.6% 66.70 USD 2,001,000
2024-05-02 2024-05-02 B Purchase

LUDWIG EDWARD J

Non-Executive Director
1,000 +4.8%
53.88
USD 53,879 		1,000 +4.8% 53.88 USD 53,879
2024-05-02 2024-05-02 B Purchase

Mahoney Michael F

Non-Executive Director
9,181 +5246.3%
54.49
USD 500,294 		9,181 +5246.3% 54.49 USD 500,294
2024-02-16 2024-02-16 S Sale

Shah Prem S

EVP and Pres-Pharm, Consumer W

Officer
29,473 -42.6%
76.95
USD 2,267,947 		29,473 -42.6% 76.95 USD 2,267,947
2023-11-06 2023-11-03 B Purchase

LUDWIG EDWARD J

Non-Executive Director
2,000 +10.7%
70.47
USD 140,930 		2,000 +10.7% 70.47 USD 140,930
2023-08-04 2023-08-03 S Sale

Clark James David

SVP, Cont & Chief Acct Officer

Officer
23,128 -83.1%
74.94
USD 1,733,212 		23,128 -83.1% 74.94 USD 1,733,212
2023-08-04 2023-08-03 S Sale

Clark James David

SVP, Cont & Chief Acct Officer

Officer
2,631 -8.6%
74.79
USD 196,792 		2,631 -8.6% 74.79 USD 196,792
2023-05-05 2023-05-03 B Purchase

Lynch Karen S

President and CEO

Executive Director
14,000 +3.4%
69.75
USD 976,567 		14,000 +3.4% 69.75 USD 976,567
2022-12-16 2022-12-15 PS Planned sale

Moriarty Thomas M

EVP & General Counsel

Officer
36,490 -5.7%
98.24
USD 3,584,869 		36,490 -5.7% 98.24 USD 3,584,869
2022-12-16 2022-12-15 PS Planned sale

Moriarty Thomas M

EVP & General Counsel

Officer
100,976 -14.2%
98.40
USD 9,936,311 		100,976 -14.2% 98.40 USD 9,936,311
2022-08-05 2022-08-04 PS Planned sale

Lotvin Alan

EVP&President-PharmacyServices

Officer
22,541 -17.1%
104.00
USD 2,344,264 		22,541 -17.1% 104.00 USD 2,344,264
2022-08-05 2022-08-03 PS Planned sale

Lotvin Alan

EVP&President-PharmacyServices

Officer
50,501 -31.6%
98.00
USD 4,949,098 		50,501 -31.6% 98.00 USD 4,949,098
// ... existing code ...